Bristol Myers Pulmonary Fibrosis Drug Admilparant Met Main Goal at 60 mg, but Higher Dose Missed
BMS said Admilparant met its phase 3 goal in pulmonary fibrosis at 60 mg, but 120 mg missed. Data are topline. What patients and families should know.
Medical Daily ·